Treatment with bazedoxifene, a selective estrogen receptor modulator, causes regression of endometriosis in a mouse model
about
Endometriosis: where are we and where are we going?Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifenePathogenesis of Endometriosis: Roles of Retinoids and Inflammatory PathwaysThe endometrium as a source of mesenchymal stem cells for regenerative medicineEmerging therapy for endometriosisEffects of ospemifene on the female reproductive and urinary tracts: translation from preclinical models into clinical evidenceTissue selective estrogen complex combinations with bazedoxifene/conjugated estrogens as a model.The dynamics of nuclear receptors and nuclear receptor coregulators in the pathogenesis of endometriosis.Treatment with bazedoxifene and conjugated estrogens results in regression of endometriosis in a murine model.The Role of Stem Cells in the Etiology and Pathophysiology of Endometriosis.Innovations in classical hormonal targets for endometriosis.Estrogen-induced CCN1 is critical for establishment of endometriosis-like lesions in miceRole of estrogen receptor signaling required for endometriosis-like lesion establishment in a mouse model.Multiple Beneficial Roles of Repressor of Estrogen Receptor Activity (REA) in Suppressing the Progression of Endometriosis.The molecular mechanisms underlying the pharmacological actions of estrogens, SERMs and oxysterols: implications for the treatment and prevention of osteoporosisEstrogen receptors and human disease: an update.Dual suppression of estrogenic and inflammatory activities for targeting of endometriosisEndometriosis impairs bone marrow-derived stem cell recruitment to the uterus whereas bazedoxifene treatment leads to endometriosis regression and improved uterine stem cell engraftment.Evolution of the tissue selective estrogen complex (TSEC).Stem Cell Markers Describe a Transition From Somatic to Pluripotent Cell States in a Rat Model of Endometriosis.Emerging hormonal treatments for menopausal symptoms.Experimental treatments of endometriosis.An overview of early drug development for endometriosis.Endometrial Cancer-Associated FGF18 Expression Is Reduced by Bazedoxifene in Human Endometrial Stromal Cells In Vitro and in Murine Endometrium.Cardiovascular safety of conjugated estrogens plus bazedoxifene: meta-analysis of the SMART trials.Correlation of changes of (non)exfoliated endometrial organelles and expressions of Musashi-1 and β-catenin with endometriosis in menstrual period.SR-16234, a Novel Selective Estrogen Receptor Modulator for Pain Symptoms with Endometriosis: An Open-label Clinical Trial.Medical Therapies for Endometriosis Differentially Inhibit Stem Cell Recruitment.Differential mRNA expression profiling in ovarian endometriotic tissue with versus without leuprolide acetate treatment.Bazedoxifene/conjugated estrogens in combination with leuprolide for the treatment of endometriosis.The ginsenoside PPD exerts anti-endometriosis effects by suppressing estrogen receptor-mediated inhibition of endometrial stromal cell autophagy and NK cell cytotoxicity.The Investigation and Management of Adenomyosis in Women Who Wish to Improve or Preserve Fertility.New insights on the pathogenesis of endometriosis and novel non-surgical therapies
P2860
Q26750772-B67817E7-7643-4D8E-8FC9-7E2953E46B8EQ26751149-20341848-DB6F-4189-A3F4-C37AAB682CC3Q28083420-1347AB62-48ED-4965-861E-1A34881F70F8Q28087579-4B3168E5-8245-4057-89BA-3D0B863BB869Q28262987-EC5D4633-B26C-45F9-97A3-4459DF9B9E73Q30380010-4CD806C8-B0CC-4079-8051-9A0B8E7CDDE9Q30456770-1B7F3379-E25E-4F46-87D9-F1C9EC29927DQ33778690-8EE31CBC-B95C-42D7-B6A3-6F6A60AE0678Q33888331-FF4DCAE4-552E-4D2B-B664-14C1DA1366B4Q34494399-488A7718-5720-4B9F-ACB1-F1DEFDB1F1C9Q34504377-26BE3B27-21A0-4469-9B27-121DB093305CQ34603067-EDE6CB19-E16E-409E-910A-E241FA79CE93Q36114008-AA78BD5A-F884-4694-B6E9-04032B05C709Q36521137-CDCB9EA7-24CE-4825-995A-F2AE65B5D9CDQ36553435-01C1CE84-FAD5-49F9-A52D-6EA2F066C0A0Q36661810-B77AB455-6E34-4A0C-BD57-00290A20F284Q36683035-583589BF-9582-47E8-B848-B7F5405B233AQ37648048-A57E6075-5DBE-4D1B-838E-F38AB4663C45Q38077503-C273CFCC-056A-4E6B-9F12-207239B1C7DCQ38288612-DE0E46E8-86ED-4761-A4F4-2C3C7A497FD1Q38307019-F3711E96-A23F-47C8-89C3-7DB3C0BC74B8Q38575273-C5D72406-4ACF-489D-AADE-3551FCF4DD98Q38653393-372F0F18-EDA2-4C5F-B1DB-474C46F14651Q41640781-25C8B402-298B-4448-9841-EC14C49B6716Q41685808-32785483-859F-4089-A461-3965F3966ECAQ42464651-23897743-429C-4608-8941-78A704E1996EQ49407072-2C5375B0-F07F-4F1F-883A-75696B8FA984Q50236230-4D165AD2-6A34-41B8-B88A-DD5A7B4F8A02Q53343858-D19E2349-3791-49FC-9238-10D0870FC7B7Q54980466-7CC3F0F6-73D3-4B60-A07F-F15F5B8A9D69Q54988198-CC141156-E2ED-4320-911A-AFAC5ECB3F01Q55266620-147DD140-9162-4209-87FE-A05894435EC4Q58799203-7464E9D5-032A-42D4-80AD-3ED991A8FF82
P2860
Treatment with bazedoxifene, a selective estrogen receptor modulator, causes regression of endometriosis in a mouse model
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Treatment with bazedoxifene, a ...... endometriosis in a mouse model
@ast
Treatment with bazedoxifene, a ...... endometriosis in a mouse model
@en
type
label
Treatment with bazedoxifene, a ...... endometriosis in a mouse model
@ast
Treatment with bazedoxifene, a ...... endometriosis in a mouse model
@en
prefLabel
Treatment with bazedoxifene, a ...... endometriosis in a mouse model
@ast
Treatment with bazedoxifene, a ...... endometriosis in a mouse model
@en
P2093
P2860
P356
P1433
P1476
Treatment with bazedoxifene, a ...... endometriosis in a mouse model
@en
P2093
Barry Komm
Catha Fischer
Hugh S Taylor
P2860
P304
P356
10.1210/EN.2010-1010
P407
P50
P577
2011-05-17T00:00:00Z